A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Formoterol

Formoterol relaxes airway muscles to relieve bronchospasm in asthma and COPD.

First FDA approval2021-06-22
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
$1.55/unit
13 NDCs benchmarked, lowest of all strengths.
Average NADAC
$1.71
Across all dosage forms in distribution.
Highest NADAC
$1.90
Range is tight.
Plans with PA
97 / 329
Limited PA friction.

Questions a plan sponsor actually asks.

FAQPage schema7 entries indexed · 4 visible
What is Formoterol used for?

Formoterol relaxes airway muscles to relieve bronchospasm in asthma and COPD.

Is there a generic for Formoterol?

No. Formoterol is brand-only with no generic equivalents currently in market.

How much does my plan pay for Formoterol?

Across 329 Part D plans, Formoterol averages $1.71/unit (NADAC). Lowest available: $1.55/unit. Highest in distribution: $1.90/unit.

Is Formoterol on the FDA shortage list?

No. Formoterol is not currently on the FDA Drug Shortage Database.

3 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

beta2-Adrenergic Agonist4 alternatives in D1
01
Arformoterol
beta2-Adrenergic Agonist
$0.653Lowest NADAC
16Generic mfrs
$8.4MCY24 Part D spend
Compare →
02
Formoterol Fumarate
Brand: FORMOTEROL FUMARATE
$1.55Lowest NADAC
10Generic mfrs
$10.5MCY24 Part D spend
Compare →
03
Levalbuterol
Brand: Levalbuterol
$0.256Lowest NADAC
7Generic mfrs
$29.7MCY24 Part D spend
Compare →
04
Levalbuterol Inhalation
Brand: levalbuterol inhalation
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (13 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.